Table of Content

1. Introduction

1.1 Market Definition
1.2 Currency Conversion


2. Research Methodology


3. Executive Summary


4. Global Epilepsy Drugs Market (2013 – 2025)


5. Market Share – Global Epilepsy Drugs (2013 – 2025)

5.1 By Country
5.2 By Drugs Category
5.3 By Drugs


6. Country - Global Epilepsy Drugs Market Analysis (2013 – 2025)

6.1 United States
6.2 United Kingdom
6.3 France
6.4 Germany
6.5 Italy
6.6 Spain
6.7 India
6.8 China
6.9 Japan


7. By Drugs Category - Global Epilepsy Drugs Market Analysis (2013 – 2025)

7.1 First Generation
7.2 Second Generation
7.3 Third Generation


8. By Drugs - Global Epilepsy Drugs Market Analysis (2013 – 2025)

8.1 Vimpat (Lacosamide)
8.2 Keppra (Levetiracetam)
8.3 Sabril (Vigabatrin)
8.4 Onfi (Clobazam)
8.5 Fycompa
8.6 Briviact (Brivaracetam)
8.7 Epidiolex
8.8 Cenobamate (YKP3089)


9. Growth Drivers

9.1 Growing Awareness Programs Worldwide
9.2 Presence of Promising Pipeline for Epilepsy Therapeutics


10. Challenges

10.1 New Restrictions on Epilepsy Drug
10.2 High Cost of Antiepileptic Drugs


11. Eisai Co., Ltd.

11.1 Company Overview
11.2 Initiatives/Activities

11.2.1 Point 1
11.2.2 Point 2
11.2.3 Point 3

11.3 Financial Insight


12. UCB Inc.

12.1 Company Overview
12.2 Initiatives/Activities

12.2.1 Point 1
12.2.2 Point 2
12.2.3 Point 3
12.2.4 Point 4

12.3 Financial Insight


13. H. Lundbeck A/S

13.1 Company Overview
13.2 Initiatives/Activities

13.2.1 Point 1
13.2.2 Point 2
13.2.3 Point 3

13.3 Financial Insight


14. GW Pharmaceuticals Plc.

14.1 Company Overview
14.2 Initiatives/Activities

14.2.1 Point 1
14.2.2 Point 2

14.3 Financial Insight



List of Figures


List of Figures

:

Figure 4?1: Global - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 4?2: Global – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025

Figure 5?1: Global - Epilepsy Drugs Market Country Share (Percent), 2013 – 2018
Figure 5?2: Global – Forecast for Epilepsy Drugs Market Country Share (Percent), 2019 – 2025
Figure 5?3: Global - Epilepsy Drugs Category Market Share (Percent), 2013 – 2018
Figure 5?4: Global – Forecast for Epilepsy Drugs Category Market Share (Percent), 2019 – 2025
Figure 5?5: Global - Epilepsy Drugs Market Share (Percent), 2013 – 2018
Figure 5?6: Global – Forecast for Epilepsy Drugs Market Share (Percent), 2019 – 2025

Figure 6?1: United States - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?2: United States – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?3: United Kingdom - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?4: United Kingdom – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?5: France - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?6: France – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?7: Germany - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?8: Germany – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?9: Italy - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?10: Italy – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?11: Spain - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?12: Spain – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?13: India - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?14: India – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?15: China - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?16: China – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 6?17: Japan - Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 6?18: Japan – Forecast for Epilepsy Drugs Market (Million US$), 2019 – 2025

Figure 7?1: Global - First Generation Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 7?2: Global – Forecast for First Generation Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 7?3: Global - Second Generation Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 7?4: Global – Forecast for Second Generation Epilepsy Drugs Market (Million US$), 2019 – 2025
Figure 7?5: Global - Third Generation Epilepsy Drugs Market (Million US$), 2013 – 2018
Figure 7?6: Global – Forecast for Third Generation Epilepsy Drugs Market (Million US$), 2019 – 2025

Figure 8?1: Global Epilepsy Drugs Market – Vimpat (Lacosamide) Sales (Million US$), 2013 – 2018
Figure 8?2: Global Epilepsy Drugs Market – Forecast for Vimpat (Lacosamide) Sales (Million US$), 2019 – 2025
Figure 8?3: Global Epilepsy Drugs Market – Keppra (Levetiracetam) Sales (Million US$), 2013 – 2018
Figure 8?4: Global Epilepsy Drugs Market – Forecast for Keppra (Levetiracetam) Sales (Million US$), 2019 – 2025
Figure 8?5: Global Epilepsy Drugs Market – Sabril (Vigabatrin) Sales (Million US$), 2013 – 2018
Figure 8?6: Global Epilepsy Drugs Market – Forecast for Sabril (Vigabatrin) Sales (Million US$), 2019 – 2025
Figure 8?7: Global Epilepsy Drugs Market – Onfi (Clobazam) Sales (Million US$), 2013 – 2018
Figure 8?8: Global Epilepsy Drugs Market – Forecast for Onfi (Clobazam) Sales (Million US$), 2019 – 2025
Figure 8?9: Global Epilepsy Drugs Market – Fycompa Sales (Million US$), 2015 – 2018
Figure 8?10: Global Epilepsy Drugs Market – Forecast for Fycompa Sales (Million US$), 2019 – 2025
Figure 8?11: Global Epilepsy Drugs Market – Briviact (Brivaracetam) Sales (Million US$), 2016 – 2018
Figure 8?12: Global Epilepsy Drugs Market – Forecast for Briviact (Brivaracetam) Sales (Million US$), 2019 – 2025
Figure 8?13: Global Epilepsy Drugs Market – Present & Forecast for Epidiolex Sales (Million US$), 2018 – 2025
Figure 8?14: Global Epilepsy Drugs Market – Forecast for Cenobamate (YKP3089) Sales (Million US$), 2019 – 2025

Figure 9?1: Global - Epilepsy Therapeutics Studies (Number), November 2018

Figure 11?1: Eisai Co., Ltd – Global Sales (Million US$), 2013 – 2018
Figure 11?2: Eisai Co., Ltd – Forecast for Global Sales (Million US$), 2019 – 2025

Figure 12?1: UCB Inc. – Global Sales (Million US$), 2013 – 2018
Figure 12?2: UCB Inc. – Forecast for Global Sales (Million US$), 2019 – 2025

Figure 13?1: Lundbeck – Global Sales (Million US$), 2013 – 2018
Figure 13?2: Lundbeck – Forecast for Global Sales (Million US$), 2019 – 2025

Figure 14?1: GW Pharmaceuticals – Global Revenue (Million US$), 2013 – 2018
Figure 14?2: GW Pharmaceuticals – Forecast for Global Revenue (Million US$), 2019 – 2025

 

List of Tables


N/A